» Articles » PMID: 21538056

Early Postoperative CEA Level is a Better Prognostic Indicator Than is Preoperative CEA Level in Predicting Prognosis of Patients with Curable Colorectal Cancer

Overview
Date 2011 May 4
PMID 21538056
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Carcinoembryonic antigen (CEA) measurements performed preoperatively and during the early postoperative period were examined prospectively to assess their prognostic value for colorectal cancer (CRC) patients receiving curative surgery.

Methods: Between 2000 and 2004, 1,361 patients with CRC who underwent curative surgery at the Taipei Veterans General Hospital were enrolled prospectively. CEA was measured prior to surgery and during the third or fourth postoperative week. The endpoint was length of postoperative disease-free survival, and prognostic importance was determined using the log-rank test and Cox regression hazard model.

Results: Six hundred (44.1%) CRC patients had high CEA concentrations preoperatively, and 188 (13.8%) patients retained high values postoperatively. Within the median follow-up period of 61 (6-108) months, CRC recurred in 313 patients. By univariate analysis TNM staging, tumor differentiation, lymphovascular invasion, preoperative CEA concentration, and postoperative CEA concentration affected the outcome. By multivariate analysis, the prognostic importance of postoperative CEA was retained (95% CI, 1.73-3.01; HR = 2.28) but that of preoperative CEA was lost (95% CI, 0.82-1.33; HR = 1.05). CRC recurred earlier in patients with high postoperative CEA concentrations; metastasis to the liver was common (72.3%) among patients in this group.

Conclusions: Early postoperative CEA concentration is an independent prognostic factor for CRC. Patients with high postoperative CEA values should receive aggressive follow-up examinations for early relapse of CRC, with special attention paid to recurrence at the liver.

Citing Articles

Prognostic Impact of the Postoperative Carcinoembryonic Antigen Level after Curative Resection of Locally Advanced Rectal Cancer.

Tsukamoto R, Sugimoto K, Ii Y, Irie T, Kawaguchi M, Kobari A J Anus Rectum Colon. 2025; 9(1):69-78.

PMID: 39882227 PMC: 11772802. DOI: 10.23922/jarc.2024-035.


Association of preoperative and recurrent serum carcinoembryonic antigen and outcome of colorectal cancer patients with metastatic relapse.

Tong S, Wu R, Zhang L, Lu P, Hu X, Li Y Heliyon. 2024; 10(7):e29347.

PMID: 38617920 PMC: 11015133. DOI: 10.1016/j.heliyon.2024.e29347.


Prognostic factors associated with early recurrence following liver resection for colorectal liver metastases: a systematic review and meta-analysis.

Tian Y, Wang Y, Wen N, Wang S, Li B, Liu G BMC Cancer. 2024; 24(1):426.

PMID: 38584263 PMC: 11000331. DOI: 10.1186/s12885-024-12162-4.


Prognostic value of dynamic changes of pre- and post-operative tumor markers in colorectal cancer.

Ren G, Zheng G, Du K, Dang Z, Dan H, Dou X Clin Transl Oncol. 2024; 26(8):2047-2059.

PMID: 38453817 DOI: 10.1007/s12094-024-03429-0.


Prognostic role of serum carcinoembryonic antigen in patients receiving liver resection for colorectal cancer liver metastasis: A meta-analysis.

Tang F, Huang C, Tang Z, Lu S, Bai T, Huang Q World J Gastrointest Surg. 2024; 15(12):2890-2906.

PMID: 38222018 PMC: 10784827. DOI: 10.4240/wjgs.v15.i12.2890.


References
1.
Locker G, Hamilton S, Harris J, Jessup J, Kemeny N, Macdonald J . ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol. 2006; 24(33):5313-27. DOI: 10.1200/JCO.2006.08.2644. View

2.
Bast Jr R, Ravdin P, Hayes D, Bates S, Fritsche Jr H, Jessup J . 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2001; 19(6):1865-78. DOI: 10.1200/JCO.2001.19.6.1865. View

3.
Tsai H, Chu K, Huang Y, Su Y, Wu J, Kuo C . Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection. J Surg Oncol. 2009; 100(8):736-43. DOI: 10.1002/jso.21404. View

4.
Kaiser A, Kang J, Chan L, Beart R . The prognostic impact of the time interval to recurrence for the mortality in recurrent colorectal cancer. Colorectal Dis. 2006; 8(8):696-703. DOI: 10.1111/j.1463-1318.2006.01017.x. View

5.
Takagawa R, Fujii S, Ohta M, Nagano Y, Kunisaki C, Yamagishi S . Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer. Ann Surg Oncol. 2008; 15(12):3433-9. DOI: 10.1245/s10434-008-0168-8. View